Stockscreener 앱 받기
332.27
1.20%
3.93
시간 외 거래:
332.27
전일 마감가:
$328.34
열려 있는:
$333.85
하루 거래량:
167.86K
Relative Volume:
0.41
시가총액:
$9.83B
수익:
$417.30M
순이익/손실:
$225.03M
주가수익비율:
44.41
EPS:
7.4815
순현금흐름:
$237.38M
1주 성능:
+1.78%
1개월 성능:
-2.11%
6개월 성능:
+20.19%
1년 성능:
+121.03%
1일 변동 폭
$320.62
$333.85
1주일 범위
$320.62
$336.28
52주 변동 폭
$136.73
$382.54
Krystal Biotech Inc Stock (KRYS) Company Profile
명칭
Krystal Biotech Inc
전화
(412) 586-5830
주소
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
332.27 | 9.85B | 417.30M | 225.03M | 237.38M | 7.4815 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | Wolfe Research | Peer Perform |
| 2026-01-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-03-05 | 개시 | Jefferies | Buy |
| 2024-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 개시 | Citigroup | Buy |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-18 | 개시 | Stifel | Buy |
| 2023-02-28 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-18 | 개시 | BofA Securities | Buy |
| 2021-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-06-04 | 개시 | Evercore ISI | Outperform |
| 2019-09-24 | 개시 | Goldman | Neutral |
| 2019-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-24 | 재확인 | Chardan Capital Markets | Buy |
| 2019-06-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-30 | 개시 | Guggenheim | Buy |
| 2018-09-11 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
State of Wyoming Buys New Stake in Krystal Biotech, Inc. $KRYS - marketbeat.com
Should Surging Vyjuvek-Driven Earnings Reshape How Krystal Biotech (KRYS) Investors View Its Risk Profile? - simplywall.st
Krystal Biotech (NASDAQ:KRYS) Upgraded to "Moderate Buy" at Royal Bank Of Canada - marketbeat.com
Krystal Biotech (KRYS) Director Dino Rossi Sells 25,000 Shares - GuruFocus
Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common Stock - moomoo.com
Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares - Investing.com
Dino Rossi Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - marketbeat.com
Krystal Biotech, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
RBC Capital Initiates Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $400 - moomoo.com
KRYS Looks 0.5% Undervalued on GF Value™ - GuruFocus
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says - marketscreener.com
KRYS Initiates Coverage by RBC Capital -- Rating Set to Outperfo - GuruFocus
Krystal Bio wins bullish view at RBC Capital Markets (KRYS) - Seeking Alpha
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More - Yahoo Finance
RBC Initiates Krystal Biotech at Outperform, With $400 Price Target - marketscreener.com
KRYSTAL BIOTECH, INC. : RBC INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $400 - Bitget
Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus - Sahm
Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK
Wolfe Research Maintains Krystal Biotech(KRYS.US) With Hold Rating - Moomoo
Trading Systems Reacting to (KRYS) Volatility - news.stocktradersdaily.com
Bank of America Corp DE Increases Stock Position in Krystal Biotech, Inc. $KRYS - marketbeat.com
Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript - The Globe and Mail
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Renaissance Technologies LLC Has $2.48 Million Stock Position in Krystal Biotech, Inc. $KRYS - marketbeat.com
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run - Yahoo Finance
Krystal Biotech Inc (KRYS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Krystal Biotech (NASDAQ:KRYS) Upgraded at Chardan Capital - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance
California State Teachers Retirement System Has $6.76 Million Holdings in Krystal Biotech, Inc. $KRYS - marketbeat.com
Krystal Biotech, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:KRYS) 2026-08-05 - Seeking Alpha
Krystal Biotech (KRYS) After Its Q2 Beat Is The Valuation Case Still Intact - Sahm
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus - Yahoo Finance
Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $386 - Moomoo
Krystal Biotech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Brokers Issue Forecasts for Krystal Biotech FY2026 Earnings - MarketBeat
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: VYJUVEK Sales Surge 24% as ... By GuruFocus - Investing.com Canada
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: V - GuruFocus
Is Krystal Biotech (KRYS) Overvalued After Q2 Earnings Beat? EPS of $1.85 & Revenue of $119.2M; GF Score: 54/100 - GuruFocus
Why Is Krystal Biotech (KRYS) Dropping 7.0%? - AlphaStreet
Krystal Biotech stock falls 7% on revenue miss despite earnings beat - Investing.com South Africa
krystal biotech vyjuvek revenue rises 24 percent - grafa.com
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's What Happened - MarketBeat
Krystal Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Krystal Biotech Inc Earnings Call Transcript - GuruFocus
Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results - The Manila Times
Earnings Flash (KRYS) Krystal Biotech Posts Q2 EPS $1.79, vs. FactSet Est of $1.62 - marketscreener.com
Krystal Biotech Inc (KRYS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):